Exchange Traded Concepts’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,126
Closed -$121K 1520
2025
Q1
$121K Sell
10,126
-3,260
-24% -$44.5K ﹤0.01% 1088
2024
Q4
$196K Hold
13,386
﹤0.01% 999
2024
Q3
$168K Sell
13,386
-6,794
-34% -$74K ﹤0.01% 1017
2024
Q2
$172K Sell
20,180
-6,276
-24% -$55.9K ﹤0.01% 892
2024
Q1
$278K Buy
26,456
+5,839
+28% +$64.8K 0.01% 835
2023
Q4
$214K Buy
20,617
+5,228
+34% +$41.7K 0.01% 784
2023
Q3
$97.6K Sell
15,389
-1,139
-7% -$8.41K ﹤0.01% 904
2023
Q2
$143K Buy
+16,528
New +$148K ﹤0.01% 855

Other funds holding ZYME

Exchange Traded Concepts's ZYME Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Zymeworks (ZYME) in Q2 2025, closing a stake of 10,126 shares — an estimated $121K sold.

Exchange Traded Concepts first reported a position in ZYME in Q2 2023 and held it in 8 quarters. The position peaked at $278K in Q1 2024. 181 funds tracked by Wall St. Rank hold ZYME as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Zymeworks position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 10,126 Zymeworks shares in Q2 2025, an estimated $121K.
  • Exchange Traded Concepts first reported a position in Zymeworks in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's Zymeworks position peaked at $278K in Q1 2024.
  • 181 funds tracked by Wall St. Rank held Zymeworks as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.